Learn More
Medchemexpress LLC Taprenepag isopropyl | 1005549-94-9 | 99.0% | 520.60 | 50 MG

Supplier: Medchemexpress LLC HY1999850MG
Taprenepag isopropyl is a highly selective EP2 receptor agonist. In preclinical studies, administration of Taprenepag isopropyl led to a reduction in intraocular pressure (IOP) in dose-dependent manner. Clinical trials have investigated its potential in conditions such as Primary Open-Angle Glaucoma and Ocular Hypertension.
- Highly selective receptor interaction
- Demonstrates significant reduction in intraocular pressure in animal models
- Evaluated in clinical trials for specific ocular conditions
- Solid, white to off-white appearance
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.